Treatment patterns of patients with BRAF-mutant metastatic colorectal cancer: Results from the German Tumor Registry Colorectal Cancer (TKK Registry)

被引：0

作者：

Zahn, M. -O. ^{[1
]}

Doerfel, S. ^{[2
]}

Schnell, R.

Wolf, T. ^{[3
]}

Vehling-Kaiser, U. ^{[4
]}

Kruggel, L. ^{[5
]}

Jaenicke, M. ^{[5
]}

Wetzel, N. ^{[5
]}

Marschner, N.

机构：

[1] Studienzentrum MVZ Onkol Kooperat Harz, Goslar, Germany

[2] Onkozentrum Dresden Freiberg, Dresden, Germany

[3] BAG Onkol Gemeinschaftspraxis, Dresden, Germany

[4] Hamatologisch Onkol Tagesklin, Landshut, Germany

[5] iOMEDICO, Freiburg, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

158

引用

页码：129 / 129

页数：1

共 50 条

[41] Comment on: “Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry”
Chaoran Yu
Targeted Oncology, 2019, 14 : 365 - 366
[42] Comment on: "Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry"
Yu, Chaoran
TARGETED ONCOLOGY, 2019, 14 (03) : 365 - 366
[43] THE MAPK PATHWAY IS A THERAPEUTIC TARGET IN BRAF-MUTANT COLORECTAL CANCER
不详
CANCER DISCOVERY, 2015, 5 (11) : 1122 - 1122
[44] A moving target: challenges in treating BRAF-mutant colorectal cancer
Scott, Aaron J.
Leong, Stephen
Messersmith, Wells A.
Lieu, Christopher H.
COLORECTAL CANCER, 2013, 2 (03) : 197 - 204
[45] Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models
Maione, Federica
Oddo, Daniele
Galvagno, Federica
Falcomata, Chiara
Pandini, Marta
Macagno, Marco
Pessei, Valeria
Barault, Ludovic
Gigliotti, Chiara
Mira, Alessia
Corti, Giorgio
Lamba, Simona
Riganti, Chiara
Castella, Barbara
Massaia, Massimo
Rad, Roland
Saur, Dieter
Bardelli, Alberto
Di Nicolantonio, Federica
MOLECULAR ONCOLOGY, 2024, 18 (06) : 1552 - 1570
[46] Targeting BRAF-Mutant Colorectal Cancer: Progress in Combination Strategies
Sundar, Raghav
Hong, David S.
Kopetz, Scott
Yap, Timothy A.
CANCER DISCOVERY, 2017, 7 (06) : 558 - 560
[47] Survival in BRAF-mutant metastatic melanoma in the real-world setting: results from the Dutch Melanoma Treatment Registry
Schouwenburg, M.
Jochems, A.
Aarts, M.
van den Berkmortel, F.
van den Eertwegh, A.
Franken, M.
Groenewegen, G.
de Groot, J-W.
Haanen, J. B. A. G.
Hospers, G.
Kapiteijn, E.
Koornstra, R.
Kruit, W.
Louwman, M.
Piersma, D.
van Rijn, R.
Ten Tije, A. J.
Vreugdenhil, G.
Wouters, M.
van der Hoeven, J.
ANNALS OF ONCOLOGY, 2016, 27
[48] BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer
Falchook, Gerald S.
Millward, Michael
Hong, David
Naing, Aung
Piha-Paul, Sarina
Waguespack, Steven G.
Cabanillas, Maria E.
Sherman, Steven I.
Ma, Bo
Curtis, Martin
Goodman, Vicki
Kurzrock, Razelle
THYROID, 2015, 25 (01) : 71 - 77
[49] Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG
Haist, Maximilian
Stege, Henner
Rogall, Friederike
Tan, Yuqi
von Wasielewski, Imke
Klespe, Kai Christian
Meier, Friedegund
Mohr, Peter
Kaehler, Katharina C.
Weichenthal, Michael
Hauschild, Axel
Schadendorf, Dirk
Ugurel, Selma
Lodde, Georg
Zimmer, Lisa
Gutzmer, Ralf
Debus, Dirk
Schilling, Bastian
Kreuter, Alexander
Ulrich, Jens
Meiss, Frank
Herbst, Rudolf
Forschner, Andrea
Leiter, Ulrike
Pfoehler, Claudia
Kaatz, Martin
Ziller, Fabian
Hassel, Jessica C.
Tronnier, Michael
Sachse, Michael
Dippel, Edgar
Terheyden, Patrick
Berking, Carola
Heppt, Markus, V
Kiecker, Felix
Haferkamp, Sebastian
Gebhardt, Christoffer
Simon, Jan Christoph
Grabbe, Stephan
Loquai, Carmen
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
[50] Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
Xu, Ting
Li, Jian
Wang, Zhenghang
Zhang, Xiaotian
Zhou, Jun
Lu, Zhihao
Shen, Lin
Wang, Xicheng
CANCER MEDICINE, 2023, 12 (09): : 10473 - 10484

← 1 2 3 4 5 →